AAAAAA

   
Results: 1-14 |
Results: 14
Radiotherapy in primary orbital lymphoma outcome and late side effects
Authors: Cama, GC Cante, D Pacelli, R Solla, R Chianese, E Manzo, R Punzo, G Cella, L Morra, A Alterio, D Alberti, D Vassallo, P Salvatore, M
Citation: Gc. Cama et al., Radiotherapy in primary orbital lymphoma outcome and late side effects, TUMORI, 87(4), 2001, pp. S120-S120
A case report of a primary NHL of the lacrimal sac
Authors: Cante, D Solla, R Manzo, R Chianese, E Punzo, G Cella, L Vassallo, P Morra, A Alterio, D Alberti, D Pacelli, R Cama, GC
Citation: D. Cante et al., A case report of a primary NHL of the lacrimal sac, TUMORI, 87(4), 2001, pp. S148-S148
A cause of late graft dysfunction after liver transplantation in children:De-novo autoimmune hepatitis
Authors: Spada, M Bertani, A Sonzogni, A Petz, W Riva, S Torre, G Melzi, ML Alberti, D Colledan, M Segalin, A Lucianetti, A Gridelli, B
Citation: M. Spada et al., A cause of late graft dysfunction after liver transplantation in children:De-novo autoimmune hepatitis, TRANSPLAN P, 33(1-2), 2001, pp. 1747-1748
Circulating EBV-DNA in the monitoring of EBV infection in pediatric liver transplant recipients
Authors: Spada, M Guizzetti, M Petz, W Colledan, M Segalin, A Lucianetti, A Bertani, A Peloni, G Sonzogni, A Alberti, D Riva, S Melzi, M Gridelli, B
Citation: M. Spada et al., Circulating EBV-DNA in the monitoring of EBV infection in pediatric liver transplant recipients, TRANSPLAN P, 33(1-2), 2001, pp. 1835-1837
Pharmacosurveillance and quality of care of thalassaemic patients - A large scale epidemiological survey
Authors: Arboretti, R Tognoni, G Alberti, D
Citation: R. Arboretti et al., Pharmacosurveillance and quality of care of thalassaemic patients - A large scale epidemiological survey, EUR J CL PH, 56(12), 2001, pp. 915-922
Phase I clinical and pharmacokinetic study of perillyl alcohol administered four times a day
Authors: Ripple, GH Gould, MN Arzoomanian, RZ Alberti, D Feierabend, C Simon, K Binger, K Tutsch, KD Pomplun, M Wahamaki, M Marnocha, R Wilding, G Bailey, HH
Citation: Gh. Ripple et al., Phase I clinical and pharmacokinetic study of perillyl alcohol administered four times a day, CLIN CANC R, 6(2), 2000, pp. 390-396
Congenital absence of portal vein with nodular regenerative hyperplasia ofthe liver
Authors: Grazioli, L Alberti, D Olivetti, L Rigamonti, W Codazzi, F Matricardi, L Fugazzola, C Chiesa, A
Citation: L. Grazioli et al., Congenital absence of portal vein with nodular regenerative hyperplasia ofthe liver, EUR RADIOL, 10(5), 2000, pp. 820-825
Treatment of extrahepatic portal hypertension in children by mesenteric-to-left portal vein bypass: a new physiological procedure
Authors: de Goyet, JD Alberti, D Falchetti, D Rigamonti, W Matricardi, L Clapuyt, P Sokal, EM Otte, JB Caccia, G
Citation: Jd. De Goyet et al., Treatment of extrahepatic portal hypertension in children by mesenteric-to-left portal vein bypass: a new physiological procedure, EURO J SURG, 165(8), 1999, pp. 777-781
Phase I trial of intravenous thymidine and carboplatin in patients with advanced cancer
Authors: Robins, HI Tutsch, K Katschinski, DM Jacobson, E Mehta, M Olsen, M Cohen, JD Tiggelaar, CL Arzoomanian, RZ Alberti, D Feierabend, C Wilding, G
Citation: Hi. Robins et al., Phase I trial of intravenous thymidine and carboplatin in patients with advanced cancer, J CL ONCOL, 17(9), 1999, pp. 2922-2931
A pilot study of melphalan, tumor necrosis factor-alpha and 41.8 degrees Cwhole-body hyperthermia
Authors: Robins, HI Katschinski, DM Longo, W Grosen, E Wilding, G Gillis, W Kraemer, C Tiggelaar, CL Stewart, JA Spriggs, D Arzoomanian, RZ Feierabend, C Alberti, D Morgan, K Simon, K d'Oleire, F
Citation: Hi. Robins et al., A pilot study of melphalan, tumor necrosis factor-alpha and 41.8 degrees Cwhole-body hyperthermia, CANC CHEMOT, 43(5), 1999, pp. 409-414
Phase I clinical and pharmacokinetic study of an one-hour infusion of ormaplatin (NSC 363812)
Authors: Tutsch, KD Arzoomanian, RZ Alberti, D Tombes, MB Feierabend, C Robins, HI Spriggs, DR Wilding, G
Citation: Kd. Tutsch et al., Phase I clinical and pharmacokinetic study of an one-hour infusion of ormaplatin (NSC 363812), INV NEW DR, 17(1), 1999, pp. 63-72
Angiotensin-converting enzyme inhibitors and kidney protection: The AIPRI trial
Authors: Maschio, G Alberti, D Locatelli, F Mann, JFE Motolese, M Ponticelli, C Ritz, E Janin, G Zucchelli, P Marai, P Marcelli, D Tentori, F Andriani, M Drago, G Meneghel, G Oldrizzi, L Rugiu, C Salvadeo, A Villa, G Picardi, L Borghi, M Moriggi, M Vendramin, G Fusaroli, M Esposti, ED Fabbri, A Zucchelli, P Zuccali, A Gaggi, R Ponticelli, C Rivolta, E Buccianti, G Gastaldi, L Baratelli, M Pedrini, L Faranna, P Cairo, G Ferrari, L Albertazzi, A Cappelli, P Canti, P Limido, A Mioni, G Montanaro, D Sasdelli, M Imperiali, P Cagnoli, L Rigotti, A Grassi, C Orazi, E Borgatti, PP Stefani, A Redaelli, B Vigan, MR Giangrande, A Ramello, A Imbasciati, E Palla, R Sessa, A Aitieri, P Verzetti, G Baroni, C Costanzo, R Bandiani, G Ducret, F Pointet, P Janin, G Nefti, H Maret, J Cledes, J Cordonnier, D Sirajedin, K Aparicio, M Mery, JP Idatte, JM Bariety, J Wolf, C Marichal, JF Koch, KM Frey, U Schaeffer, J Ritz, E Mann, J Schweitzer, C Stahl-Blaser, R Mann-Sterzel, J Oberdorf, E Lachein, L Bosselmann, HP Schmidt, R Irmhild, H Stein, G Laske, N
Citation: G. Maschio et al., Angiotensin-converting enzyme inhibitors and kidney protection: The AIPRI trial, J CARDIO PH, 33, 1999, pp. S16-S20
The spleen in the Wiskott-Aldrich syndrome - Histopathologic abnormalitiesof the white pulp correlate with the clinical phenotype of the disease
Authors: Vermi, W Blanzuoli, L Kraus, MD Grigolato, P Donato, F Loffredo, G Marino, CE Alberti, D Notarangelo, LD Facchetti, F
Citation: W. Vermi et al., The spleen in the Wiskott-Aldrich syndrome - Histopathologic abnormalitiesof the white pulp correlate with the clinical phenotype of the disease, AM J SURG P, 23(2), 1999, pp. 182-191
Asymptomatic giant gastric lipoma: What to do?
Authors: Alberti, D Grazioli, L Orizio, P Matricardi, L Dughi, S Gheza, L Falchetti, D Caccia, G
Citation: D. Alberti et al., Asymptomatic giant gastric lipoma: What to do?, AM J GASTRO, 94(12), 1999, pp. 3634-3637
Risultati: 1-14 |